skip to main content
usmle step 2 ck

Research Ethics

Human subjects research requires scientific validity, IRB review, informed consent, fair subject selection, risk minimization, and special protections for vulnerable populations

Review date
reviewed 2026-05-04
Reading time
9 min read
Author
Dr Kola Tytler MBBS CertHE MBA MSt MRCGP
Ethics, Law & Patient Safetycommonresearch
On this page
Condition details
Ethics, Law & Patient Safety
common
9 min read
reviewed 2026-05-04
practice step 2 ck questions →

About This Page

This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.

Key points

  • Belmont principles: respect for persons, beneficence, and justice
  • Most human subjects research requires IRB review before recruitment begins
  • Research informed consent must explain purpose, procedures, risks, benefits, alternatives, confidentiality, voluntariness, and right to withdraw
  • Clinical equipoise means genuine uncertainty in the expert community about which study arm is superior
  • Vulnerable populations require additional safeguards against coercion, exploitation, and impaired voluntariness

Overview

Research ethics protects human subjects while allowing socially valuable science. The Belmont Report provides the classic US framework: respect for persons, beneficence, and justice. The Common Rule and Office for Human Research Protections regulations operationalize these principles through IRB review, informed consent requirements, risk-benefit assessment, and additional protections for vulnerable populations.

Core Ethical Framework

Respect for persons requires voluntary informed consent and protection for people with diminished autonomy. Beneficence requires minimizing risks and maximizing possible benefits. Justice requires fair subject selection so burdens and benefits of research are not distributed unfairly. Scientific validity is also ethical: exposing participants to risk for a poorly designed study is not justified. Researchers must distinguish clinical care from research and avoid implying that trial participation is guaranteed therapy.

When This Issue Arises

Symptoms
Research Ethics is raised by a high-stakes decision, conflict, request, or safety issue requiring structured ethical/legal analysis
Patient, family, institution, or clinician preferences are in tension
Delay, coercion, misunderstanding, or lack of documentation could cause patient harm
State law, hospital policy, or formal reporting pathway may control the next step
A vulnerable patient or public safety interest may be involved
Signs
Clear documentation of patient values, capacity, authority, and medical facts supports the decision
Unclear authority, serious disagreement, or immediate danger requires escalation
Professional standards require honesty, proportionality, and patient-centered communication
Ethics consultation is useful for persistent conflict but does not replace urgent safety action
Court or legal involvement is reserved for unresolved authority disputes or state-law requirements

Assessment Steps

First-line
Clarify the decisionDefine exactly what is being requested, refused, disclosed, reported, or studied
Assess capacity and authorityIdentify whether the patient can decide and, if not, who has legal authority
Assess immediate safetyDo not delay emergency stabilization, protection of vulnerable persons, or prevention of serious imminent harm
Second-line
Apply the governing standardUse patient autonomy, substituted judgment, best interests, mandatory reporting, EMTALA, HIPAA, or IRB standards as appropriate
Communicate and documentUse plain language, document the reasoning, and record who participated in the decision
Use institutional pathwaysInvolve ethics, legal, risk management, privacy, OPO, IRB, or public health teams when indicated
Specialist
Ethics consultationUse for unresolved conflict, values uncertainty, or medically ineffective treatment requests
Legal/risk management or institutional authorityUse when law, court order, reporting, or external regulatory obligation is involved

Management

HHS OHRP Common Rule Guidance and the Belmont Report
1
Immediate approach
  • Stabilize the patient or protect safety first
  • Clarify the medical facts and the specific decision at issue
  • Assess decision-making capacity, voluntariness, and legal authority
  • Use professional interpreters and private conversation when relevant
2
Ethical/legal standard
  • Honor capacitated patient preferences unless a specific legal exception applies
  • Use substituted judgment before best interests when the patient lacks capacity
  • Apply mandatory reporting and public health exceptions when required
  • Avoid coercion, abandonment, concealment, and medically ineffective care
3
Escalation
  • Involve ethics committee for persistent conflict
  • Involve legal/risk management for court orders, guardianship, EMTALA, HIPAA, or mandatory reporting uncertainty
  • Use specialist teams such as OPO, IRB, palliative care, psychiatry, or child protection when indicated
4
Documentation
  • Document facts, capacity/authority, discussion, alternatives, final decision, and follow-up plan
  • Avoid speculative or blame-focused documentation
  • Reassess if circumstances or capacity change

Common Pitfalls

  • Do not skip the first step: Define the decision and assess capacity or authority before acting.
  • Do not use family preference as patient preference: Surrogates should represent patient values, not their own goals.
  • Do not ignore safety exceptions: Mandatory reporting, imminent threats, and emergency obligations can override ordinary confidentiality.
  • Do not overuse legal escalation: Court involvement is not first-line when routine surrogate or emergency pathways apply.
  • Document clearly: Ethics answers often turn on whether the reasoning and communication were properly recorded.
USMLE Step 2 CK Exam Tips
  • 1Research study involving patients: obtain IRB approval before recruitment
  • 2Belmont principles: respect for persons, beneficence, justice
  • 3Clinical equipoise is required for randomization in an RCT
  • 4Placebo is inappropriate when proven effective therapy exists and withholding it risks serious harm
  • 5Prisoners and children are vulnerable populations requiring extra protections
  • 6Therapeutic misconception: patient thinks the trial is designed primarily to benefit them personally
  • 7Large payment to poor participants can be undue inducement
  • 8Financial conflicts must be disclosed and managed, not hidden

Put your reading into practice

Topic-specific question practice is not linked for this article yet.

Choose USMLE Step 2 CK questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.

Choose USMLE Step 2 CK practice

After your session, return to this section to revisit the reading and choose your next review.

Verified Sources & References

HHS OHRP — The Belmont Report
HHS OHRP — Informed Consent Guidance
HHS OHRP — Vulnerable Populations
Your learning path

Save your place and choose what comes next

sign in to save your learning

Ethics, Law & Patient Safety · Article 14 of 14